| Thin basement membrane nephropathy J Savige, K Rana, S Tonna, M Buzza, H Dagher, YY Wang Kidney international 64 (4), 1169-1178, 2003 | 289 | 2003 |
| Intense exercise for survival among men with metastatic castrate-resistant prostate cancer (INTERVAL-GAP4): a multicentre, randomised, controlled phase III study protocol RU Newton, SA Kenfield, NH Hart, JM Chan, KS Courneya, J Catto, ... BMJ open 8 (5), e022899, 2018 | 107 | 2018 |
| COL4A4 mutation in thin basement membrane disease previously described in Alport syndrome M Buzza, YY Wang, H Dagher, JJ Babon, RG Cotton, H Powell, J Dowling, ... Kidney international 60 (2), 480-483, 2001 | 101 | 2001 |
| Mutations in the COL4A4 gene in thin basement membrane disease M Buzza, H Dagher, YY Wang, D Wilson, JJ Babon, RG Cotton, J Savige Kidney international 63 (2), 447-453, 2003 | 98 | 2003 |
| Segregation of hematuria in thin basement membrane disease with haplotypes at the loci for Alport syndrome M Buzza, D Wilson, J Savige Kidney international 59 (5), 1670-1676, 2001 | 93 | 2001 |
| Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient‐derived xenograft (PDX) models NM Navone, WM van Weerden, RL Vessella, ED Williams, Y Wang, ... The Prostate 78 (16), 1262-1282, 2018 | 92 | 2018 |
| A comparison of the clinical, histopathologic, and ultrastructural phenotypes in carriers of X-linked and autosomal recessive Alport's syndrome H Dagher, M Buzza, D Colville, C Jones, H Powell, R Fassett, D Wilson, ... American journal of kidney diseases 38 (6), 1217-1228, 2001 | 74 | 2001 |
| Reasons for discontinuing active surveillance: assessment of 21 centres in 12 countries in the Movember GAP3 Consortium M Van Hemelrijck, X Ji, J Helleman, MJ Roobol, W van der Linden, ... European urology 75 (3), 523-531, 2019 | 70 | 2019 |
| Understanding the plasmapheresis donor in a voluntary, nonremunerated environment LL Bove, T Bednall, B Masser, M Buzza Transfusion, 2011 | 69 | 2011 |
| The Movember Foundation's GAP3 cohort: a profile of the largest global prostate cancer active surveillance database to date SM Bruinsma, L Zhang, MJ Roobol, CH Bangma, EW Steyerberg, ... BJU international 121 (5), 737-744, 2018 | 64 | 2018 |
| Perceived deterrents to being a plasmapheresis donor in a voluntary, nonremunerated environment KL Bagot, LL Bove, BM Masser, TC Bednall, M Buzza Transfusion 53 (5), 1108-1119, 2013 | 54 | 2013 |
| The genetics of thin basement membrane nephropathy K Rana, YY Wang, M Buzza, S Tonna, KW Zhang, T Lin, L Sin, ... Seminars in nephrology 25 (3), 163-170, 2005 | 48 | 2005 |
| Clinical, histopathologic, and genetic studies in nine families with focal segmental glomerulosclerosis K Rana, N Isbel, M Buzza, H Dagher, P Henning, G Kainer, J Savige American journal of kidney diseases 41 (6), 1170-1178, 2003 | 35 | 2003 |
| Persistent familial hematuria in children and the locus for thin basement membrane nephropathy K Rana, YY Wang, H Powell, C Jones, D McCredie, M Buzza, M Udawela, ... Pediatric Nephrology 20, 1729-1737, 2005 | 27 | 2005 |
| The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needs MM Kouspou, JE Fong, N Brew, STF Hsiao, SL Davidson, PL Choyke, ... Nature Reviews Urology 17 (9), 499-512, 2020 | 24 | 2020 |
| Adherence to active surveillance protocols for low-risk prostate cancer: results of the Movember foundation’s global action plan prostate cancer active surveillance initiative AA Kalapara, JFM Verbeek, D Nieboer, M Fahey, V Gnanapragasam, ... European urology oncology 3 (1), 80-91, 2020 | 23 | 2020 |
| Predicting biopsy outcomes during active surveillance for prostate cancer: external validation of the canary prostate active surveillance study risk calculators in five large … FJH Drost, D Nieboer, TM Morgan, PR Carroll, MJ Roobol, B Trock, ... European urology 76 (5), 693-702, 2019 | 20 | 2019 |
| Apolipoprotein AI and CIII gene polymorphisms and their association with lipid levels in Italian, Greek and Anglo-Irish populations of Australia M Buzza, J Fripp Yvonne, Mitchell Annals of Human Biology 28 (5), 481- 490., 2001 | 18 | 2001 |
| Haematuria in asymptomatic individuals: It is often caused by inherited thinning of the glomerular membrane J Savige, M Buzza, H Dagher BMJ 322 (7292), 942-943, 2001 | 17 | 2001 |
| A prospective trial assessing the safety and efficacy of collecting up to 840 mL of plasma in conjunction with saline infusion during plasmapheresis M Buzza, DC Marks, H Capper, E Cassin, CA Badcock, S Reid, M Kwok, ... Transfusion 52 (8), 1806-1813, 2012 | 15 | 2012 |
